Financial Markets Institutions and Instruments · 2019 · 41 citations · 11 references
LawBusiness LawControlled Substances RegulationDrug LawRegulatory AffairsCannabis RegulationDrug EnforcementFederal Controlled Substance LawFutures MarketsLegal RiskRegulatory RiskCannabis Banking RegulationCannabis Finance RegulationCannabis TaxationControlled Substances ActFutures Market RiskFutures Market StructureLegal Risk ManagementMarket Price Risk
Abstract Thirty states and the District of Columbia have legalized the use of cannabis for medicinal and/or recreational use by either formally or informally de‐criminalizing its use. However, cannabis remains a Schedule 1 drug under the Federal Controlled Substances Act (21 U.S.C. Sections 801 through 812), leaving federal law in conflict with the laws of over half of the states. As a result, market participants in legal cannabis businesses face risks due to the industry's unique legal status within the United States. We examine the risks and challenges deemed by the cannabis industry as the top risks facing the industry's continued future growth and its sustainability. In addition to general risks inherent in a nascent industry, a legal cannabis business faces additional risks, such as risks in its banking and finance activity, placement of insurance, payment of taxes, and managing its supply chain. These legal businesses also face true legal risk from the possibility of being shut down by the federal government and seizure of assets and product under the CSA. This paper also examines whether the cannabis industry would benefit from a futures market to mitigate price risk.
11
Competitive Strategy: Techniques for Analyzing Industries and Competitors
Michael E. Porter · 1980 · 16.8K citations
TECHNOLOGY AND COMPETITIVE ADVANTAGE
Michael E. Porter · Journal of Business Strategy · 1985 · 1.1K citations
PRODUCTION, PRIMARY, SECONDARY AND TERTIARY
Allan G. B. Fisher · Economic Record · 1939 · 668 citations
Life Sciences, Secondary Education, Manufacturing Processes +11
What Price Data Tell Us about Drug Markets
Jonathan P. Caulkins, Peter Reuter · Journal of Drug Issues · 1998 · 265 citations